Drugs / Venezuelan Equine Encephalitis DNA Vaccine
Venezuelan Equine Encephalitis DNA Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06002503 | Oct 2023 → May 2025 | vaccinia | PharmaJet, Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Venezuelan Equine Encephalitis DNA Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06002503 ↗ |
| Modality | Vaccine | “Venezuelan Equine Encephalitis DNA Vaccine Candidate” NCT06002503 ↗ |
| Route | Intramuscular | “Route (device): Intramuscular” NCT06002503 ↗ |